
- BioPharm International-09-15-2017
- Volume 2017 eBook
- Issue 2
Overcoming Hurdles in Emerging Therapy Development
The development of emerging therapies poses unique manufacturing and formulation challenges for drug developers as candidates like cell and gene therapies advance through the pipeline.
As precision medicines garner increasing attention, drug makers have intensified their efforts to bring emerging therapies such as cell and gene therapies to market. This article gives an overview of cell/gene therapies in the making and explores the challenges biomanufacturers face in developing and manufacturing such inherently complex molecules. Unlike traditional small-molecule drugs and conventional antibody-based biologics, the roadblocks to developing and manufacturing cell and gene therapies can get complicated because of their molecular complexity and the fact that their mechanisms of action are not fully understood.
Download the
.
Article Details
BioPharm International eBook: Development Strategies for Emerging Therapies
Vol. 30
September 2017
Pages: 4-9
Citation
When referring to this article, please cite it as F. Mirasol, "Overcoming Hurdles in Emerging Therapy Development, " BioPharm International Development Strategies for Emerging Therapies eBook (September 2017).
Articles in this issue
about 8 years ago
Patenting Prospects for Cell-Based Therapiesabout 8 years ago
Harvest of Human Mesenchymal Stem Cells from Microcarriersabout 8 years ago
End-to-End Cell Therapy Automation: An Immunotherapy Case Studyabout 8 years ago
Optimizing a Unique Cancer Vaccine for Intradermal Deliveryabout 8 years ago
Accelerating Genetic Medicine R&D Using MicrofluidicsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.